Paperpal Prime Logo

Journal of Rheumatology : Impact Factor & More

eISSN: 1499-2752pISSN: 0315-162X

Aims and Scope of Journal of Rheumatology

The Journal of Rheumatology is a peer-reviewed medical journal addressing topics in rheumatology and arthritis. It is an official journal of the Canadian Rheumatology Association. Since 1992, the journal has published the proceedings of Outcome Measures in Rheumatoid Arthritis Clinical Trials (OMERACT) conferences. Less

Key Metrics

CiteScore
6.8
Eigenfactor
0.01 - 0.05
Impact Factor
< 5
SJR
Q2Immunology
SNIP
1.45
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Rheumatology

Journal of Rheumatology Journal Specifications

Overview
Publisher J RHEUMATOL PUBL CO
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1974
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Journal of Rheumatology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Rheumatology

Effect of Bimekizumab Treatment on Health Status, Work Productivity, and Productivity Costs Through 3 Years in Axial Spondyloarthritis and Psoriatic Arthritis.
  • 7 Aug 2026
  • The Journal of rheumatology
Do People With Tophaceous Gout Require More Allopurinol for Good Clinical Outcomes? Analysis of 2 Randomized Controlled Trials of Allopurinol Dose Escalation.
  • 1 Aug 2026
  • The Journal of rheumatology
Clinical Meaningfulness and Improvement Thresholds of Myositis Core Set Measures: Association with Patient-Reported Outcomes.
  • 1 Aug 2026
  • The Journal of rheumatology
Dr. Singh replies.
  • 1 Aug 2026
  • The Journal of rheumatology
Bimekizumab Long-Term Safety and Efficacy Across the Spectrum of Axial Spondyloarthritis Over 3 Years: Results From 2 Phase III Studies.
  • 1 Aug 2026
  • The Journal of rheumatology
Understanding the impact of meeting performance measures on the outcomes of joint replacement in rheumatoid arthritis: a population-based study in British Columbia, Canada.
  • 1 Aug 2026
  • The Journal of rheumatology
Effect of Bimekizumab Treatment on Health Status, Work Productivity, and Productivity Costs Through 3 Years in Axial Spondyloarthritis and Psoriatic Arthritis.
  • 7 Aug 2026
  • The Journal of rheumatology
Do People With Tophaceous Gout Require More Allopurinol for Good Clinical Outcomes? Analysis of 2 Randomized Controlled Trials of Allopurinol Dose Escalation.
  • 1 Aug 2026
  • The Journal of rheumatology
Clinical Meaningfulness and Improvement Thresholds of Myositis Core Set Measures: Association with Patient-Reported Outcomes.
  • 1 Aug 2026
  • The Journal of rheumatology
Dr. Singh replies.
  • 1 Aug 2026
  • The Journal of rheumatology
Bimekizumab Long-Term Safety and Efficacy Across the Spectrum of Axial Spondyloarthritis Over 3 Years: Results From 2 Phase III Studies.
  • 1 Aug 2026
  • The Journal of rheumatology
Understanding the impact of meeting performance measures on the outcomes of joint replacement in rheumatoid arthritis: a population-based study in British Columbia, Canada.
  • 1 Aug 2026
  • The Journal of rheumatology

FAQs on Journal of Rheumatology